Emmaus Life Sciences (EMMA) Receivables (2010 - 2026)
Emmaus Life Sciences (EMMA) recorded Receivables of $709,000 in Q2 2026, down 65.8% from $2.07 million a year earlier and down 65.4% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Receivables (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences reported Receivables of $2.8 million, up 6.9% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 37.3% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $2.62 million in FY2024 (-52.5%), $5.52 million in FY2023, $375,000 in FY2022 (-63.9%) and $1.04 million in FY2021 (+81.2%).
- The Q2 2026 figure is the lowest quarterly Receivables since Q4 2022.
- On a year-over-year basis, Receivables rose in two of the last eight quarters, with an average decline of 29.7%.
- Peak year-over-year performance for Receivables in the last five years was growth of 351.3% in Q2 2023, against a decline of 68.1% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.05 million (Q1 2026), $2.8 million (Q4 2025) and $2.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | 709,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709,000.00 |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 938,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 2.66 Mn |
API Access
Emmaus Life Sciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();